Fundraising Fox

Mitch Gold

Investor

Venture Partner at Frazier Life Sciences

Seattle

About

Mitch Gold joined Frazier Life Sciences as a Venture Partner in 2025, focusing on company creation, with over 25 years as a biotech executive. He co-founded Alpine Immune Sciences and served as its CEO and Executive Chairman from 2015 until its 2024 sale to Vertex Pharmaceuticals, and previously founded Alpine Biosciences and the venture firm Alpine Bioventures, as well as leading Dendreon Corporation as CEO and Chairman. He holds an M.D. from Rush Medical College and a B.S. in Biology from the University of Wisconsin-Madison.

Invests in

Biotech

Experience

  1. Stealth Mode BiotechExecutive Chairmancurrent2025 β€” presentSan Francisco Bay Area
  2. Dor CapitalManaging Partnercurrent2025 β€” present
  3. Attovia TherapeuticsBoard Membercurrent2024 β€” present
  4. Alpine BioVenturesManaging Partnercurrent2013 β€” present
  5. Frazier Life SciencesVenture Partner2025 β€” 2026
  6. Alpine Immune SciencesCo-founder Executive Chairman and CEO2015 β€” 2024Seattle
  7. Alpine BiosciencesFounder And Chairman2012 β€” 2014
  8. Dendreon CorporationChairman Of The Board2012 β€” 2013
  9. DendreonPresident and CEO2001 β€” 2012Greater Seattle Area
  10. Data CriticalVP of Business Development2000 β€” 2001
  11. ElixisPresident and CEO1995 β€” 2000

Education

  1. University of Washington - School of MedicineUrology1993 β€” 1998
  2. Rush Medical College of Rush University Medical CenterMD1989 β€” 1993
  3. University of Wisconsin-MadisonBS, Biology1985 β€” 1989

Skills & more

Biotechnology38Cancer Research12Prostate Cancer5Medicare/Medicaid reimbursement6FDA24

From Mitch's professional profile.

Same school

Shared employers

Investments

Per the firm's website.

Colleagues at Frazier Life Sciences